- お問い合わせ
- AFS
- Business
- Bussiness
- Car
- Career
- Celebrity
- Digital Products
- Education
- Entertainment
- Fashion
- Film
- Food
- Fun
- Games
- General Health
- Health
- Health Awareness
- Healthy
- Healthy Lifestyle
- History Facts
- Household Appliances
- Internet
- Investment
- Law
- Lifestyle
- Loans&Mortgages
- Luxury Life Style
- movie
- Music
- Nature
- News
- Opinion
- Pet
- Plant
- Politics
- Recommends
- Science
- Self-care
- services
- Smart Phone
- Sports
- Style
- Technology
- tire
- Travel
- US
- World

Dec 3 (Reuters) - Lockheed Martin said on Wednesday it has opened a hypersonics system integration lab at its Huntsville campus as it pushes to develop next-generation weapons.
Hypersonic weapons, which can travel at more than five times the speed of sound and evade traditional defenses, are at the centre of an arms race between the United States and China.
Lockheed's 17,000-square-foot facility will include advanced test equipment, simulation tools and an integration environment.
It is part of a larger capital program that now totals roughly $529 million and includes 719,000 square feet of facilities under construction or planned, the company said.
"Hypersonic weapons are reshaping the future of military defense by delivering unmatched speed and maneuverability that outpace traditional threats," said Holly Molmer, program management director for Lockheed Martin
In October, defense start-up Castelion said it won contracts to integrate its Blackbeard hypersonic strike weapon with current U.S. Army systems.
(Reporting by Aishwarya Jain in Bengaluru; Editing by Shailesh Kuber)
最近の投稿
- 1
FDA claims on COVID-19 vaccine safety are unsupported by reliable data – and could severely hinder vaccine access - 2
Germany and trade unions kick off tough public-sector wage talks - 3
Five killed in Israeli air strikes on tents near Khan Younis, medics say - 4
A single shot of HPV vaccine may be enough to fight cervical cancer, study finds - 5
A single shot of HPV vaccine may be enough to fight cervical cancer, study finds
Novo Nordisk cuts Wegovy price as CEO pledges to go 'all in' on weight loss pill
Bayer reports positive results for blood thinner after 2023 setback
Peloton recalls more than 800,000 bikes after broken seat posts injure users
FDA adds strongest warning to Sarepta gene therapy linked to 2 patient deaths
Emergent Cold LatAm opens state-of-the-art cold storage hub in Guadalajara
Wizz CEO: We’re going to invest $1 b. in Israeli market
Amazon sued over 'punitive' handling of employee absences
FDA adds strongest warning to Sarepta gene therapy linked to 2 patient deaths
The cheap health insurance promoted by Trump officials has this catch











